SETD2 and nonpapillary renal cell carcinoma: Our results demonstrate that overexpressed LEDGF in ccRCC regulates gene transcription of key enzymes in the nucleotide de novo synthesis pathway by binding to H3R17me2a, leading to metabolic reprogramming of nucleotides, and thereby promoting excessive proliferation of SETD2 mutant ccRCC cells.